Alejandro Soza
Alejandro Soza
Verified email at - Homepage
Cited by
Cited by
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis
K Promrat, G Lutchman, GI Uwaifo, RJ Freedman, A Soza, T Heller, E Doo, ...
Hepatology 39 (1), 188-196, 2004
Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculous peritonitis: a meta-analysis
A Riquelme, M Calvo, F Salech, S Valderrama, A Pattillo, M Arellano, ...
Journal of clinical gastroenterology 40 (8), 705-710, 2006
Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C
A Soza, JE Everhart, MG Ghany, E Doo, T Heller, K Promrat, Y Park, ...
Hepatology 36 (5), 1273-1279, 2002
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
C Cerda, RM Pérez-Ayuso, A Riquelme, A Soza, P Villaseca, ...
Journal of hepatology 47 (3), 412-417, 2007
Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass
C Boza, A Riquelme, L Ibañez, I Duarte, E Norero, P Viviani, A Soza, ...
Obesity surgery 15 (8), 1148-1153, 2005
Non‐alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C‐reactive protein in Hispanics
A Riquelme, M Arrese, A Soza, A Morales, R Baudrand, RM Pérez‐Ayuso, ...
Liver international 29 (1), 82-88, 2009
Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C
K Promrat, DH McDermott, CM Gonzalez, DE Kleiner, DE Koziol, M Lessie, ...
Gastroenterology 124 (2), 352-360, 2003
Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin
JH Hoofnagle, MG Ghany, DE Kleiner, E Doo, T Heller, K Promrat, J Ong, ...
Hepatology 38 (1), 66-74, 2003
The liver in times of COVID-19: What hepatologists should know
E Ridruejo, A Soza
Annals of hepatology 19 (4), 353-358, 2020
Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials
GJ Dore, B Conway, Y Luo, E Janczewska, B Knysz, Y Liu, ...
Journal of hepatology 64 (1), 19-28, 2016
Liver transplantation for hepatocellular carcinoma: evaluation of the alpha‐fetoprotein model in a multicenter cohort from Latin America
F Piñero, M Tisi Baña, EC de Ataide, S Hoyos Duque, S Marciano, ...
Liver International 36 (11), 1657-1667, 2016
Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review
JP Arab, R Candia, R Zapata, C Muñoz, JP Arancibia, J Poniachik, ...
World Journal of Gastroenterology: WJG 20 (34), 12182, 2014
Platelet count/spleen diameter ratio for non-invasive prediction of high risk esophageal varices in cirrhotic patients
F Barrera, A Riquelme, A Soza, Á Contreras, G Barrios, O Padilla, ...
Annals of Hepatology 8 (4), 325-330, 2009
Increased orocecal transit time in patients with nonalcoholic fatty liver disease
A Soza, A Riquelme, R GonzÁlez, M Alvarez, RM Pérez-Ayuso, ...
Digestive diseases and sciences 50, 1136-1140, 2005
Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up
F Salech, S Valderrama, B Nervi, JC Rodriguez, D Oksenberg, A Koch, ...
Annals of hepatology 10 (1), 99-102, 2016
Treatment with direct‐acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma
F Piñero, M Mendizabal, E Ridruejo, F Herz Wolff, B Ameigeiras, ...
Liver International 39 (6), 1033-1043, 2019
High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data
LA Díaz, F Idalsoaga, M Cannistra, R Candia, D Cabrera, F Barrera, ...
World journal of gastroenterology 26 (48), 7693, 2020
Analysis of natural variants of the hepatitis C virus internal ribosome entry site reveals that primary sequence plays a key role in cap-independent translation
MI Barría, A Gonzalez, J Vera-Otarola, U Leon, V Vollrath, D Marsac, ...
Nucleic acids research 37 (3), 957-971, 2009
Disease progression in patients with hepatitis C virus infection treated with direct-acting antiviral agents
M Mendizabal, F Piñero, E Ridruejo, FH Wolff, M Anders, V Reggiardo, ...
Clinical Gastroenterology and Hepatology 18 (11), 2554-2563. e3, 2020
Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study
M Gabrielli, F Moisan, M Vidal, I Duarte, M Jiménez, G Izquierdo, ...
Annals of Hepatology 11 (6), 891-898, 2012
The system can't perform the operation now. Try again later.
Articles 1–20